AbbVie stock edges higher as Berenberg lifts target; tariffs and Feb. 4 earnings in play
AbbVie shares rose 0.4% to $214.92 by midday Wednesday after Berenberg raised its price target to $275. Bernstein maintained a Hold rating with a $225 target. Investors are watching for U.S. pharma tariff developments and AbbVie’s Feb. 4 earnings. The stock traded between $211.92 and $218.00 on volume of 5.3 million shares.